A carregar...
New Antithrombotic Drugs in Acute Coronary Syndrome
In recent years, much progress has been made in the field of antithrombotic drugs in acute coronary syndrome (ACS) treatment, as reflected by the introduction of the more potent P2Y12-inhibitors prasugrel and ticagrelor, and novel forms of concomitant anticoagulation, such as fondaparinux and bivali...
Na minha lista:
| Publicado no: | J Clin Med |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
MDPI
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7408919/ https://ncbi.nlm.nih.gov/pubmed/32629976 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm9072059 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|